Alaunos Therapeutics
TCRT
$1.36
Share price
3.03%
Change (1 day)
126.67%
Change (1 year)
Categories
Operating Margin for Alaunos Therapeutics (TCRT)
Operating Margin as of May 2024 (TTM): -19,786.70%
According to Alaunos Therapeutics's latest financial reports and stock price the company's current Operating Margin is -19,786.70%. At the end of 2021 the company had an Operating Margin of -19,786.68%.
Operating Margin history for Alaunos Therapeutics from 2001 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -19,786.68% | |
| 2018 | -36,381.51% | 4178.88% |
| 2017 | -850.26% | -64.71% |
| 2016 | -2,409.23% | -13.09% |
| 2015 | -2,772.11% | 19.76% |
| 2014 | -2,314.71% | -67.57% |
| 2013 | -7,138.38% | -40.6% |
| 2012 | -12,016.50% | 12.25% |
| 2011 | -10,704.65% | |
| 2002 | -1,554.12% | -63.02% |
| 2001 | -4,202.49% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.